End of life treatments are, I assume, very profitable, because either they'll be covered by insurance, or they'll be paid by the deceased's estate. They'll probably get paid the full asking price rather than having to give a discount too.

I wouldn't argue they aren't profitable, but there is a good chance Medicare is covering it, which is substantially lower reimbursement than private insurance.

If they have a limited volume of beds, I'm sure a focus on profit would drive a private patient getting care versus an elderly Medicare patient.

If the estate can’t pay then the debt is just written off though.

That aside, ability to pay is not going to be the top consideration of the baseline profitability of a procedure.

I don’t know any specifics though.

But most people do die with an estate of some kind